Home / Clinical Decision Support & Reference / GenomOncology Precision Oncology

GenomOncology Precision Oncology

by GenomOncology · Based in United States → — Precision Decisions

Hematology Oncology Pathology

Website

Claim this tool

Is this the maker? Claim the company →

Leave this field empty

Correct company / maker

Company website (optional)

Anything else? (optional)

Overview

GenomOncology transforms complex and fragmented oncology data into actionable intelligence. The platform merges all assay and lab data into one report to increase operational efficiency, delivers transparent and explainable AI that generates real-time, auto-generated data interpretations at the point of care, automates and customizes patient treatment with unparalleled clinical trial matching, and connects seamlessly with LIS, LIMS, and EHR for automated, bidirectional data exchange. Oncology professionals face an unprecedented challenge with over 1,400 FDA indications and 15,000 active clinical trials, making clear decision-making difficult. GenomOncology’s platform aims to be the core infrastructure that unifies data, workflows, and insights across cancer care, serving as an embedded intelligence layer within oncology ecosystems.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

Automated Somatic & Germline Variant Interpretation
Clinical Trial Matching & Decision Support
Custom Molecular Pathology Reporting (HL7, PDF, XML, DOCX, TXT)
Data Extraction from Unstructured Documents (igniteIQ)
Genomic Data Visualization and Analytics (GenomAnalytics)
Molecular Tumor Board Workflow
Comprehensive API Suite for System Integration
Secure & Scalable Infrastructure
Transparent, Explainable AI
Real-time, auto-generated data interpretations

Use Cases

Accelerate reporting and eliminate bottlenecks for molecular pathologists/lab techs
Never miss a clinical trial opportunity for patients with real-time trial matching for oncologists/clinical trial professionals
Unlock the power of oncology data with automated extraction and normalization for bioinformaticians/clinical researchers
Automating genomic reporting into the EHR
Standardizing genomic variant interpretation and classification
Facilitating molecular tumor board review

What Physicians Need to Know

Evidence Base

GenomOncology's platform leverages a comprehensive knowledge base that includes FDA/EMA approved and investigational oncology agents, NCCN guidelines, and other precision oncology databases like OncoKB and CIViC. The evidence base incorporates drugs' mechanism of action, molecular target, modality, and other characteristics. It also includes extensive synonym lists and database codes from sources like NCIt, JAX-CKB, OncoTree, SNOMED, ICD-9/10, and FDA. The platform also integrates literature references via PubMed.

Literature Scope

The platform's drug ontology is expertly curated and continuously maintained, including information from databases, prescribing labels, guidelines, and publications. It supports both USA and EU therapies. The knowledge base covers over 1,400 FDA indications and more than 15,000 active clinical trials.

Clinical Validation Studies

GenomOncology's Pathology Workbench features an automated variant interpretation algorithm that has achieved a 95% concordance rate with manual interpretations. Case studies highlight the platform's ability to streamline variant analysis, validation, and support for assays like TruSight Oncology 500, enhancing precision medicine programs. One case study demonstrated that without the Pathology Workbench, two targetable variants might not have been identified, reducing the chances of a patient knowing about a matched clinical trial. The platform has been tested for clinical utility within the Johns Hopkins Molecular Tumor Board and in community settings.

Alert Fatigue Management

GenomOncology offers configurable notification preferences and allows clinicians to customize the cadence, type, and form of communication they receive. This aims to streamline cohort identification, in-house clinical trial matching, and knowledge monitoring, helping to manage the volume and complexity of new genetic discoveries and treatment options. While not explicitly detailing alert fatigue *reduction strategies* within the tool, the customization options suggest an approach to make alerts more relevant and manageable.

Drug Interaction Checking

While GenomOncology's primary focus is on genomic data interpretation and clinical trial matching, the importance of drug-drug interactions in precision oncology is recognized in the broader context of precision medicine. The platform's comprehensive drug ontology and its ability to integrate various data sources could potentially support future drug interaction checking capabilities, though this is not explicitly detailed as a current feature.

Differential Diagnosis Support

GenomOncology's tools focus on matching genomic alterations to targeted therapies and clinical trials, rather than providing differential diagnosis support. The platform helps identify actionable somatic mutations and corresponding drug targets based on the mutational profile of a tumor.

Guideline Update Frequency

The clinical trial database, containing approximately 10,000 trials with structured eligibility criteria, is updated on a nightly basis by ingesting data from clinicaltrials.gov. The in-house content and curation team continuously maintains the drug ontology and all related elements. Therapeutic information, including FDA approvals and special statuses, is also regularly updated. Annotation sets are validated quarterly.

Clinical Workflow Integration

GenomOncology's solutions are designed for seamless integration into clinical workflows. The GO API Suite enables bidirectional data flow with any LIS, EHR, or LIMS, using standards-based HL7, FHIR, and REST connectivity. The Pathology Workbench integrates directly with lab sequencers to annotate variants, match trials and therapies, and create comprehensive reports that can be integrated back into a patient's record. The platform supports flexible deployment options, including cloud, on-premise, or hybrid environments.

Decision Audit Trail

The platform's solutions deliver transparent, explainable AI that generates real-time, auto-generated data interpretations. This transparency, combined with the ability to capture treatment recommendations from molecular tumor board conferences, suggests a mechanism for tracking and auditing decisions, though a specific 'decision audit trail' feature is not explicitly detailed.

Physician Tip

GenomOncology's platform excels in providing up-to-date, evidence-based insights for precision oncology, particularly in genomic variant interpretation and clinical trial matching. Leverage the comprehensive knowledge base and real-time updates to identify relevant therapies and trials. The customizable reporting and workflow integration can streamline your practice, but be mindful of configuring alerts to avoid fatigue. While strong in genomic-driven treatment decisions, consider integrating with other tools for comprehensive drug interaction checking and differential diagnosis support.

GenomOncology's platform is highly adaptable, offering seamless integration with existing LIS, LIMS, and EHR systems through its API Suite, supporting HL7, FHIR, and REST connectivity. It can be deployed in cloud, on-premise, or hybrid environments, providing flexibility for various institutional IT infrastructures. The Pathology Workbench directly integrates with lab sequencers for an end-to-end workflow from sequencing to reporting. Customization options allow for prioritization of institutional trials and tailoring report outputs to specific clinical and reimbursement requirements.

At a glance

Deployment Cloud, On Premise, Hybrid

Visit site

Details

Category	Clinical Decision Support & Reference, Oncology AI, Pathology AI
Pricing	Unknown — unknown
Deployment	Cloud, On-premise, Hybrid
Compliance
BAA Available	Unknown AI-estimated
HIPAA Compliant	Yes AI-estimated
FDA Status	Unknown AI-estimated The PacBio HiFi WGS RUO (Research Use Only) secondary analysis pipeline, which is integrated with GenomOncology's Pathology Workbench, is not intended for use in diagnostic procedures.
Integrations
EHR	Not specified
Specialties	Hematology, Oncology, Pathology

What the Web Says

GenomOncology Precision Oncology offers a comprehensive suite of software solutions and data-driven insights designed to improve cancer care by transforming complex genomic data into actionable intelligence. Their platform assists molecular pathologists, oncologists, and researchers with tasks such as genomic reporting, clinical trial matching, and treatment decision support. The company emphasizes its end-to-end capabilities, deep integration with existing healthcare systems, and the use of AI to streamline workflows and enhance decision-making.

Overall: Positive

Strengths

Comprehensive, end-to-end solution for precision oncology from analysis to decision support.
Deep integration capabilities with existing EHR, LIMS, and in-house systems.
Automates complex variant interpretation following major guidelines (AMP/ASCO/CAP, ACMG).
Highly configurable and customizable to fit unique institutional workflows and data environments.
Includes both proprietary and licensed content for an up-to-date knowledge base.
Improves efficiency in somatic variant analysis and report generation, with positive feedback from oncologists on report clarity.

Limitations

Pricing is not transparent and likely high-cost due to enterprise focus.
Steep learning curve for non-specialized users due to the complexity of the domain and features.
Requires significant implementation and integration effort to connect to existing hospital/lab infrastructure.
Limited public reviews available to assess user satisfaction and support quality.
Some Reddit discussions suggest a lack of employee reviews online.
Precision oncology, in general, can be a long process with results that are sometimes hard to interpret at face value.

Based on reviews from: IntuitionLabs.ai, GenomOncology (About Us), GenomOncology (Precision Oncology Platform for Clinical Decision Support), GenomOncology (YouTube Channel), PR Newswire, GenomOncology (Blog), Reddit

Last updated: 2026-08-24

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate GenomOncology Precision Oncology

Clinical Value

Ease of Use

Integration

Support & Docs

Value for Money

Your Name *

Email *

Your Role

Specialty

Your Review * (min 50 characters)

Press & Coverage

MEDITECH

MEDITECH Expanse Genomics and GenomOncology integration drives targeted cancer treatments at Frederick Health

The integration of GenomOncology's Precision Oncology Platform with MEDITECH Expanse Genomics at Frederick Health has led to measurable improvements in precision oncology care, including optimized treatment plans for 96 patients and a significant increase in clinical trial referrals within six months.

2025-02

PR Newswire

GenomOncology Announces BioMCP: Open Source Model Context Protocol (MCP) for Biomedical AI Assistants and Agents

GenomOncology introduced BioMCP, an open-source technology designed to help AI systems access specialized medical information, supporting advanced searching and full-text retrieval from various biomedical data sources.

2025-04

PR Newswire

GenomOncology and Pillar Biosciences Announce Co-Marketing Partnership to Advance Rapid Precision Oncology Solutions

GenomOncology and Pillar Biosciences have formed a co-marketing partnership to integrate GenomOncology's clinical decision support platform with Pillar's targeted Next Generation Sequencing (NGS) panels, aiming to provide comprehensive workflows for personalized cancer insights.

2025-02

PR Newswire

GenomOncology Partners with Chronetyx Laboratories to Accelerate Cancer Care Through Comprehensive Genomic Profiling

GenomOncology and Chronetyx Laboratories announced a strategic partnership to reduce turnaround times for next-generation sequencing (NGS) testing results and streamline cancer care delivery through automated workflows and comprehensive genomic profiling.

2025-03

BioSpace

GenomOncology and Genomenon Partner to Enhance Germline Variant Classification and Genomic Reporting

This partnership aims to offer a more comprehensive and efficient approach to germline variant classification by integrating Genomenon's Mastermind Data with GenomOncology's Precision Oncology Platform.

2024-11

ASCO Publications

Cancer Informatics for Cancer Centers: Sharing Ideas on How to Build an Artificial Intelligenceu2013Ready Informatics Ecosystem for Radiation Oncology | JCO Clinical Cancer Informatics

Ian Maurer from GenomOncology presented on the GenomOncology Precision Oncology Platform, highlighting its role as an expert-curated knowledge base that can enhance the capabilities of generative large language models in medical question answering, biomarker annotation, and clinical trial matching.

2023-12

Business Wire

GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution

Congenica selected the GenomOncology Precision Oncology Platform for the development of a novel CE-IVD Precision Oncology Solution, aiming to transform the usability and scalability of genomic data for routine oncology clinical practice.

2022-08

BioSpace

GenomOncology Boosts Treatment Matching Capabilities with Integration of Prior Intervention Eligibility Criteria

GenomOncology's Precision Oncology Platform now integrates patients' prior intervention eligibility criteria to enhance its treatment matching algorithm and decision support capabilities, streamlining the identification of optimal treatment options.

2022-06

Videos

Product demos, reviews, and walkthroughs for GenomOncology Precision Oncology.

GenomOncology Precision Oncology Solutions

GenomOncology

GenomOncology's GO Precision Oncology

GenomOncology

GenomOncology Overview

GenomOncology

GenomOncology: Breaking Down Barriers to Precision Oncology Care

GenomOncology

igniteIQ - GenomOncology's Precision Oncology Data Enablement Solution

GenomOncology

#172: Ian Maurer (GenomOncology) u2014 Precision Oncology, Convergence of Genomics & AI, and Improvin...

Jeffrey Stern (Lay of The Land)

View all on YouTube

Frequently Asked Questions

How does GenomOncology Precision Oncology assist with clinical decision support in my practice?

GenomOncology's Precision Oncology Platform (POP) provides data-driven insights by transforming complex genomic and clinical data into actionable information. It helps streamline decision-making by offering tools for molecular pathology, clinical trial optimization, and therapy selection, integrating directly into existing workflows.

What are the key features for oncologists using GenomOncology's platform?

For oncologists, the platform offers real-time, biomarker-specific clinical trial matching, helping to identify suitable trials and avoid missed opportunities. It also provides decision support for cancer diagnosis, treatment, and management by leveraging medical data, clinical guidelines, and computational algorithms.

How does GenomOncology ensure compliance and data security?

GenomOncology's platform is designed with enterprise-grade security and HIPAA compliance, and it adheres to CAP guidelines. It integrates with existing security infrastructures and offers user roles and permissions to ensure data integrity and patient privacy.

What are the alternatives to GenomOncology for precision oncology decision support?

Several other precision oncology decision support tools exist, including MyCancerGenome and OncoKB, which are noted for their comprehensive and up-to-date information on somatic mutations. Other platforms like Tempus One and CureMatch also offer AI-driven insights and personalized treatment recommendations.

What are the typical costs associated with GenomOncology Precision Oncology, and how is pricing structured?

GenomOncology's pricing is not publicly disclosed and is structured for enterprise-level healthcare institutions and molecular laboratories. It is generally not transparent, and interested parties need to contact the company for a demo and quote.

What are the limitations or challenges a physician might encounter when using GenomOncology?

Potential limitations include a likely high cost due to its enterprise focus and a steep learning curve for non-specialized users given the complexity of the domain and features. Significant implementation and integration effort may also be required to connect with existing hospital/lab infrastructure.

How does GenomOncology integrate with existing electronic health record (EHR) systems?

GenomOncology's GO API Suite enables bidirectional data flow with any LIS, EHR, or LIMS, utilizing standards-based HL7, FHIR, and REST connectivity. This allows for seamless integration and automation of genomic reporting into the EHR.